{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:38:32Z","timestamp":1772249912024,"version":"3.50.1"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundamental Research Project of Wuhan Science and Technology Bureau","award":["No. 2023020201010157"],"award-info":[{"award-number":["No. 2023020201010157"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11882-025-01199-5","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:55:23Z","timestamp":1742176523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?"],"prefix":"10.1007","volume":"25","author":[{"given":"Qingxiu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"11","key":"1199_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, et al. Defining \u201cT cell exhaustion.\u201d Nat Rev Immunol. 2019;19(11):665\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1199_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med. 1998;187(9):1383\u201393.","journal-title":"J Exp Med"},{"issue":"7053","key":"1199_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nature04079","volume":"436","author":"DG Bowen","year":"2005","unstructured":"Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436(7053):946\u201352.","journal-title":"Nature"},{"issue":"15","key":"1199_CR4","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1128\/JVI.00889-12","volume":"86","author":"JM Angelosanto","year":"2012","unstructured":"Angelosanto JM, Blackburn SD, Crawford A, et al. Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J Virol. 2012;86(15):8161\u201370.","journal-title":"J Virol"},{"issue":"4","key":"1199_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36(4):265\u201376.","journal-title":"Trends Immunol"},{"issue":"12","key":"1199_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, et al. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19(12):775\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7562","key":"1199_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney EF, Lee JC, Jayne DR, et al. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523(7562):612\u20136.","journal-title":"Nature"},{"issue":"10","key":"1199_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fimmu.2019.00111","volume":"29","author":"G Pawelec","year":"2019","unstructured":"Pawelec G. Is there a positive side to T cell exhaustion? Front Immunol. 2019;29(10):111.","journal-title":"Front Immunol"},{"issue":"3","key":"1199_CR9","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/clt2.12130","volume":"12","author":"M Savour\u00e9","year":"2022","unstructured":"Savour\u00e9 M, Bousquet J, Jaakkola JJK, et al. Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution. Clin Transl Allergy. 2022;12(3):e12130.","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"1199_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/all.13317","volume":"73","author":"G Roberts","year":"2018","unstructured":"Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73(4):765\u201398.","journal-title":"Allergy"},{"issue":"1","key":"1199_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","volume":"138","author":"HW Virgin","year":"2009","unstructured":"Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009;138(1):30\u201350.","journal-title":"Cell"},{"issue":"5","key":"1199_CR12","doi-asserted-by":"publisher","first-page":"F19","DOI":"10.1084\/jem.193.5.F19","volume":"193","author":"RM Welsh","year":"2001","unstructured":"Welsh RM. Assessing CD8 T cell number and dysfunction in the presence of antigen. J Exp Med. 2001;193(5):F19-22.","journal-title":"J Exp Med"},{"issue":"11","key":"1199_CR13","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","volume":"78","author":"EJ Wherry","year":"2004","unstructured":"Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol. 2004;78(11):5535\u201345.","journal-title":"J Virol"},{"issue":"11","key":"1199_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nri3740","volume":"14","author":"DE Speiser","year":"2014","unstructured":"Speiser DE, Utzschneider DT, Oberle SG, et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol. 2014;14(11):768\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1199_CR15","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/JVI.02524-08","volume":"83","author":"JN Blattman","year":"2009","unstructured":"Blattman JN, Wherry EJ, Ha SJ, et al. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J Virol. 2009;83(9):4386\u201394.","journal-title":"J Virol"},{"issue":"4","key":"1199_CR16","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2015.10.054","volume":"163","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ. SnapShot: T cell exhaustion. Cell. 2015;163(4):1038-1038.e1.","journal-title":"Cell"},{"issue":"8","key":"1199_CR17","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77(8):4911\u201327.","journal-title":"J Virol"},{"issue":"8","key":"1199_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"87","key":"1199_CR19","doi-asserted-by":"publisher","first-page":"eadg868","DOI":"10.1126\/sciimmunol.adg3868","volume":"8","author":"X Lan","year":"2023","unstructured":"Lan X, Zebley CC, Youngblood B. Cellular and molecular waypoints along the path of T cell exhaustion. Sci Immunol. 2023;8(87):eadg868.","journal-title":"Sci Immunol."},{"issue":"2","key":"1199_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cyto.2014.11.024","volume":"71","author":"MY Balkhi","year":"2015","unstructured":"Balkhi MY, Ma Q, Ahmad S, et al. T cell exhaustion and Interleukin 2 downregulation. Cytokine. 2015;71(2):339\u201347.","journal-title":"Cytokine"},{"issue":"6","key":"1199_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492\u20139.","journal-title":"Nat Immunol"},{"issue":"7","key":"1199_CR22","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.4049\/jimmunol.1001783","volume":"186","author":"J Duraiswamy","year":"2011","unstructured":"Duraiswamy J, Ibegbu CC, Masopust D, et al. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. J Immunol. 2011;186(7):4200\u201312.","journal-title":"J Immunol"},{"issue":"4","key":"1199_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670\u201384.","journal-title":"Immunity"},{"issue":"6","key":"1199_CR24","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering TA, Crawford A, Angelosanto JM, et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity. 2012;37(6):1130\u201344.","journal-title":"Immunity"},{"issue":"6316","key":"1199_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen DR, Kaminski J, Barnitz RA, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354(6316):1165\u20139.","journal-title":"Science"},{"issue":"2","key":"1199_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","volume":"53","author":"W Seo","year":"2021","unstructured":"Seo W, Jerin C, Nishikawa H. Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion. Exp Mol Med. 2021;53(2):202\u20139.","journal-title":"Exp Mol Med"},{"issue":"5","key":"1199_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra JC, Manne S, Abdel-Hakeem MS, et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity. 2020;52(5):825-841.e8.","journal-title":"Immunity"},{"issue":"3","key":"1199_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, Sen DR, Al Abosy R, et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20(3):326\u201336.","journal-title":"Nat Immunol"},{"issue":"5","key":"1199_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen Z, Ji Z, Ngiow SF, et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity. 2019;51(5):840-855.e5.","journal-title":"Immunity"},{"issue":"3","key":"1199_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","volume":"35","author":"B Youngblood","year":"2011","unstructured":"Youngblood B, Oestreich KJ, Ha SJ, et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity. 2011;35(3):400\u201312.","journal-title":"Immunity"},{"issue":"1","key":"1199_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","volume":"170","author":"HE Ghoneim","year":"2017","unstructured":"Ghoneim HE, Fan Y, Moustaki A, et al. de novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell. 2017;170(1):142-157.e19.","journal-title":"Cell"},{"issue":"6","key":"1199_CR32","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.immuni.2016.10.028","volume":"45","author":"JP Scott-Browne","year":"2016","unstructured":"Scott-Browne JP, L\u00f3pez-Moyado IF, Trifari S, et al. Dynamic changes in chromatin accessibility occur in CD8+ t cells responding to viral infection. Immunity. 2016;45(6):1327\u201340.","journal-title":"Immunity"},{"issue":"7655","key":"1199_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip M, Fairchild L, Sun L, et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature. 2017;545(7655):452\u20136.","journal-title":"Nature"},{"issue":"6316","key":"1199_CR34","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken KE, Sammons MA, Odorizzi PM, et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science. 2016;354(6316):1160\u20135.","journal-title":"Science"},{"issue":"6","key":"1199_CR35","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol. 2022;23(6):848\u201360.","journal-title":"Nat Immunol"},{"issue":"7","key":"1199_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2022.06.008","volume":"40","author":"H Kissick","year":"2022","unstructured":"Kissick H, Ahmed R. New epigenetic regulators of T cell exhaustion. Cancer Cell. 2022;40(7):708\u201310.","journal-title":"Cancer Cell"},{"issue":"2","key":"1199_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/imm.13238","volume":"162","author":"JD Sears","year":"2021","unstructured":"Sears JD, Waldron KJ, Wei J, et al. Targeting metabolism to reverse T-cell exhaustion in chronic viral infections. Immunology. 2021;162(2):135\u201344.","journal-title":"Immunology"},{"issue":"2","key":"1199_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity. 2016;45(2):374\u201388.","journal-title":"Immunity"},{"issue":"2","key":"1199_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch B, Johnson AL, Kurachi M, et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity. 2016;45(2):358\u201373.","journal-title":"Immunity"},{"issue":"7251","key":"1199_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460(7251):103\u20137.","journal-title":"Nature"},{"issue":"1","key":"1199_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 2019;30(1):143-156.e5.","journal-title":"Cell Metab"},{"issue":"3","key":"1199_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167(3):829-842.e13.","journal-title":"Cell"},{"issue":"3","key":"1199_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41590-018-0045-y","volume":"19","author":"EF McKinney","year":"2018","unstructured":"McKinney EF, Smith KGC. Metabolic exhaustion in infection, cancer and autoimmunity. Nat Immunol. 2018;19(3):213\u201321.","journal-title":"Nat Immunol"},{"issue":"37","key":"1199_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"26","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;26(37):457\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"1199_CR45","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.4049\/jimmunol.1100038","volume":"188","author":"PM Odorizzi","year":"2012","unstructured":"Odorizzi PM, Wherry EJ. Inhibitory receptors on lymphocytes: insights from infections. J Immunol. 2012;188(7):2957\u201365.","journal-title":"J Immunol"},{"issue":"6332","key":"1199_CR46","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui E, Cheung J, Zhu J, et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. 2017;355(6332):1428\u201333.","journal-title":"Science"},{"issue":"6","key":"1199_CR47","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209(6):1201\u201317.","journal-title":"J Exp Med"},{"issue":"4","key":"1199_CR48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1084\/jem.20121416","volume":"210","author":"BH Zinselmeyer","year":"2013","unstructured":"Zinselmeyer BH, Heydari S, Sacrist\u00e1n C, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med. 2013;210(4):757\u201374.","journal-title":"J Exp Med"},{"issue":"4","key":"1199_CR49","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4049\/jimmunol.1400557","volume":"193","author":"RL Ferris","year":"2014","unstructured":"Ferris RL, Lu B, Kane LP. Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion. J Immunol. 2014;193(4):1525\u201330.","journal-title":"J Immunol"},{"issue":"3","key":"1199_CR50","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2004.06.017","volume":"21","author":"T Pentcheva-Hoang","year":"2004","unstructured":"Pentcheva-Hoang T, Egen JG, Wojnoonski K, et al. B7\u20131 and B7\u20132 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 2004;21(3):401\u201313.","journal-title":"Immunity"},{"issue":"7","key":"1199_CR51","first-page":"267","volume":"33","author":"M Sabzevary-Ghahfarokhi","year":"2018","unstructured":"Sabzevary-Ghahfarokhi M, Shirzad H, Rafieian-Kopaei M, et al. The role of inflammatory cytokines in creating T cell exhaustion in cancer. Cancer Biother Radiopharm. 2018;33(7):267\u201373.","journal-title":"Cancer Biother Radiopharm"},{"issue":"6129","key":"1199_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro JR, Ng C, Lee AM, et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 2013;340(6129):207\u201311.","journal-title":"Science"},{"issue":"6129","key":"1199_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson EB, Yamada DH, Elsaesser H, et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013;340(6129):202\u20137.","journal-title":"Science"},{"issue":"6","key":"1199_CR54","doi-asserted-by":"publisher","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","volume":"1","author":"T Wu","year":"2016","unstructured":"Wu T, Ji Y, Moseman EA, et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci Immunol. 2016;1(6):eaai8593.","journal-title":"Sci Immunol."},{"issue":"11","key":"1199_CR55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, Trifilo MJ, Edelmann KH, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12(11):1301\u20139.","journal-title":"Nat Med"},{"issue":"3","key":"1199_CR56","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1084\/jem.20071948","volume":"205","author":"DG Brooks","year":"2008","unstructured":"Brooks DG, Lee AM, Elsaesser H, et al. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008;205(3):533\u201341.","journal-title":"J Exp Med"},{"issue":"51","key":"1199_CR57","doi-asserted-by":"publisher","first-page":"20428","DOI":"10.1073\/pnas.0811139106","volume":"105","author":"DG Brooks","year":"2008","unstructured":"Brooks DG, Ha SJ, Elsaesser H, et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci U S A. 2008;105(51):20428\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1199_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","volume":"31","author":"R Tinoco","year":"2009","unstructured":"Tinoco R, Alcalde V, Yang Y, et al. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity. 2009;31(1):145\u201357.","journal-title":"Immunity"},{"issue":"13","key":"1199_CR59","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1128\/JVI.00164-12","volume":"86","author":"L Garidou","year":"2012","unstructured":"Garidou L, Heydari S, Gossa S, et al. Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. J Virol. 2012;86(13):7060\u201371.","journal-title":"J Virol"},{"issue":"6","key":"1199_CR60","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","volume":"20","author":"DV Sawant","year":"2019","unstructured":"Sawant DV, Yano H, Chikina M, et al. Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion. Nat Immunol. 2019;20(6):724\u201335.","journal-title":"Nat Immunol"},{"issue":"5934","key":"1199_CR61","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science. 2009;324(5934):1569\u201372.","journal-title":"Science"},{"issue":"5934","key":"1199_CR62","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science. 2009;324(5934):1572\u20136.","journal-title":"Science"},{"issue":"5934","key":"1199_CR63","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1172815","volume":"324","author":"A Fr\u00f6hlich","year":"2009","unstructured":"Fr\u00f6hlich A, Kisielow J, Schmitz I, et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009;324(5934):1576\u201380.","journal-title":"Science"},{"key":"1199_CR64","doi-asserted-by":"crossref","unstructured":"Abbas AK, Trotta E, R Simeonov D, et al. Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol. 2018;3(25): eaat1482.","DOI":"10.1126\/sciimmunol.aat1482"},{"issue":"5","key":"1199_CR65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nm866","volume":"9","author":"JN Blattman","year":"2003","unstructured":"Blattman JN, Grayson JM, Wherry EJ, et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med. 2003;9(5):540\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"1199_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DAA. T cell exhaustion. Annu Rev Immunol. 2024;42(1):179\u2013206.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"1199_CR67","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/eji.200425828","volume":"35","author":"KS Lang","year":"2005","unstructured":"Lang KS, Recher M, Navarini AA, et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol. 2005;35(3):738\u201345.","journal-title":"Eur J Immunol"},{"issue":"2","key":"1199_CR68","doi-asserted-by":"publisher","first-page":"pbac014","DOI":"10.1093\/pcmedi\/pbac014","volume":"5","author":"M Yang","year":"2022","unstructured":"Yang M, Lin C, Wang Y, et al. Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis. Precis Clin Med. 2022;5(2):pbac014.","journal-title":"Precis Clin Med."},{"issue":"4","key":"1199_CR69","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, Sowell RT, Kaech SM, et al. Metabolic instruction of immunity. Cell. 2017;169(4):570\u201386.","journal-title":"Cell"},{"issue":"1","key":"1199_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O\u2019Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166(1):63\u201376.","journal-title":"Cell"},{"issue":"12","key":"1199_CR71","doi-asserted-by":"publisher","first-page":"669456","DOI":"10.3389\/fimmu.2021.669456","volume":"7","author":"CP Martins","year":"2021","unstructured":"Martins CP, New LA, O\u2019Connor EC, et al. Glycolysis inhibition induces functional and metabolic exhaustion of cd4+ t cells in type 1 diabetes. Front Immunol. 2021;7(12):669456.","journal-title":"Front Immunol"},{"issue":"6","key":"1199_CR72","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.chom.2013.05.014","volume":"13","author":"CT Ng","year":"2013","unstructured":"Ng CT, Snell LM, Brooks DG, et al. Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe. 2013;13(6):652\u201364.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"1199_CR73","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1084\/jem.20101773","volume":"208","author":"LM Fahey","year":"2011","unstructured":"Fahey LM, Wilson EB, Elsaesser H, et al. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med. 2011;208(5):987\u201399.","journal-title":"J Exp Med"},{"issue":"12","key":"1199_CR74","doi-asserted-by":"publisher","first-page":"e005293","DOI":"10.1136\/jitc-2022-005293","volume":"10","author":"SM Khan","year":"2022","unstructured":"Khan SM, Desai R, Coxon A, et al. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. J Immunother Cancer. 2022;10(12):e005293.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"1199_CR75","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1084\/jem.20132577","volume":"211","author":"P Penaloza-MacMaster","year":"2014","unstructured":"Penaloza-MacMaster P, Kamphorst AO, Wieland A, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211(9):1905\u201318.","journal-title":"J Exp Med"},{"issue":"3","key":"1199_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.bbmt.2017.11.022","volume":"24","author":"RL Williams","year":"2018","unstructured":"Williams RL, Cooley S, Bachanova V, et al. Recipient T cell exhaustion and successful adoptive transfer of haploidentical natural killer cells. Biol Blood Marrow Transplant. 2018;24(3):618\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1199_CR77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","volume":"479\u2013480","author":"SM Kahan","year":"2015","unstructured":"Kahan SM, Wherry EJ, Zajac AJ. T cell exhaustion during persistent viral infections. Virology. 2015;479\u2013480:180\u201393.","journal-title":"Virology"},{"issue":"6","key":"1199_CR78","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.4049\/jimmunol.0902522","volume":"184","author":"IG Rodrigue-Gervais","year":"2010","unstructured":"Rodrigue-Gervais IG, Rigsby H, Jouan L, et al. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol. 2010;184(6):3134\u201344.","journal-title":"J Immunol"},{"issue":"4","key":"1199_CR79","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.2834","volume":"15","author":"M Kurachi","year":"2014","unstructured":"Kurachi M, Barnitz RA, Yosef N, et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat Immunol. 2014;15(4):373\u201383.","journal-title":"Nat Immunol"},{"issue":"10","key":"1199_CR80","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.2232","volume":"16","author":"M Quigley","year":"2010","unstructured":"Quigley M, Pereyra F, Nilsson B, et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med. 2010;16(10):1147\u201351.","journal-title":"Nat Med"},{"issue":"7764","key":"1199_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan O, Giles JR, McDonald S, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;571(7764):211\u20138.","journal-title":"Nature"},{"issue":"11","key":"1199_CR82","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1073\/pnas.0610335104","volume":"104","author":"P Agnellini","year":"2007","unstructured":"Agnellini P, Wolint P, Rehr M, et al. Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc Natl Acad Sci U S A. 2007;104(11):4565\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1199_CR83","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41590-023-01614-x","volume":"24","author":"L Till\u00e9","year":"2023","unstructured":"Till\u00e9 L, Cropp D, Charmoy M, et al. Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion. Nat Immunol. 2023;24(10):1645\u201353.","journal-title":"Nat Immunol"},{"issue":"10","key":"1199_CR84","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41590-023-01624-9","volume":"24","author":"J Buck","year":"2023","unstructured":"Buck J, Joshi NS. Cancer- and infection-induced T cell exhaustion are distinct. Nat Immunol. 2023;24(10):1604\u20135.","journal-title":"Nat Immunol"},{"issue":"2","key":"1199_CR85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-022-00833-x","volume":"23","author":"D Arcia-Anaya","year":"2023","unstructured":"Arcia-Anaya D, Elliott T. STAT5A antagonizes TOX in CD8+ T cell exhaustion. Nat Rev Immunol. 2023;23(2):73.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1199_CR86","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1084\/jem.20070841","volume":"204","author":"AM Intlekofer","year":"2007","unstructured":"Intlekofer AM, Takemoto N, Kao C, et al. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med. 2007;204(9):2015\u201321.","journal-title":"J Exp Med"},{"issue":"6","key":"1199_CR87","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man K, Gabriel SS, Liao Y, et al. Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity. 2017;47(6):1129-1141.e5.","journal-title":"Immunity"},{"issue":"7","key":"1199_CR88","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.celrep.2018.04.038","volume":"23","author":"E Stelekati","year":"2018","unstructured":"Stelekati E, Chen Z, Manne S, et al. Long-term persistence of exhausted CD8 T cells in chronic infection is regulated by MicroRNA-155. Cell Rep. 2018;23(7):2142\u201356.","journal-title":"Cell Rep"},{"issue":"7982","key":"1199_CR89","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, Zhao S, Roginsky J, et al. The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature. 2023;622(7982):383\u201392.","journal-title":"Nature"},{"issue":"6","key":"1199_CR90","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1172\/JCI26856","volume":"116","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, McGavern DB, Oldstone MB. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest. 2006;116(6):1675\u201385.","journal-title":"J Clin Invest"},{"issue":"7109","key":"1199_CR91","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350\u20134.","journal-title":"Nature"},{"issue":"7077","key":"1199_CR92","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682\u20137.","journal-title":"Nature"},{"issue":"7","key":"1199_CR93","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","volume":"134","author":"N Nakamoto","year":"2008","unstructured":"Nakamoto N, Kaplan DE, Coleclough J, et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology. 2008;134(7):1927\u201337.","journal-title":"Gastroenterology"},{"issue":"5","key":"1199_CR94","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/v15051141","volume":"15","author":"\u00c1D Apol","year":"2023","unstructured":"Apol \u00c1D, Winckelmann AA, Duus RB, et al. The role of CTLA-4 in T cell exhaustion in chronic hepatitis B virus infection. Viruses. 2023;15(5):1141.","journal-title":"Viruses"},{"issue":"2","key":"1199_CR95","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog. 2009;5(2):e1000313.","journal-title":"PLoS Pathog"},{"issue":"9","key":"1199_CR96","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.trecan.2022.04.004","volume":"8","author":"CC Zebley","year":"2022","unstructured":"Zebley CC, Youngblood B. Mechanisms of T cell exhaustion guiding next-generation immunotherapy. Trends Cancer. 2022;8(9):726\u201334.","journal-title":"Trends Cancer"},{"issue":"69","key":"1199_CR97","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"29","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto M, Kamphorst AO, Im SJ, et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med. 2018;29(69):301\u201318.","journal-title":"Annu Rev Med"},{"issue":"12","key":"1199_CR98","doi-asserted-by":"publisher","first-page":"715234","DOI":"10.3389\/fimmu.2021.715234","volume":"20","author":"JS Dolina","year":"2021","unstructured":"Dolina JS, Van Braeckel-Budimir N, Thomas GD, et al. CD8+ T cell exhaustion in cancer. Front Immunol. 2021;20(12):715234.","journal-title":"Front Immunol"},{"issue":"559","key":"1199_CR99","doi-asserted-by":"publisher","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","volume":"10","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B. CD8+ T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;10(559):216043.","journal-title":"Cancer Lett"},{"issue":"12","key":"1199_CR100","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ni.2762","volume":"14","author":"T Okazaki","year":"2013","unstructured":"Okazaki T, Chikuma S, Iwai Y, et al. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol. 2013;14(12):1212\u20138.","journal-title":"Nat Immunol"},{"issue":"26","key":"1199_CR101","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443\u201354.","journal-title":"N Engl J Med"},{"issue":"2","key":"1199_CR102","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013;369(2):134\u201344.","journal-title":"N Engl J Med"},{"issue":"39","key":"1199_CR103","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1073\/pnas.0801497105","volume":"105","author":"SD Blackburn","year":"2008","unstructured":"Blackburn SD, Shin H, Freeman GJ, et al. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc Natl Acad Sci U S A. 2008;105(39):15016\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1199_CR104","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"1199_CR105","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, Apetoh L, Sullivan JM, et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207(10):2187\u201394.","journal-title":"J Exp Med"},{"issue":"4","key":"1199_CR106","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","volume":"72","author":"SR Woo","year":"2012","unstructured":"Woo SR, Turnis ME, Goldberg MV, et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res. 2012;72(4):917\u201327.","journal-title":"Cancer Res"},{"issue":"104","key":"1199_CR107","doi-asserted-by":"publisher","first-page":"105154","DOI":"10.1016\/j.ebiom.2024.105154","volume":"14","author":"WP Lin","year":"2024","unstructured":"Lin WP, Li H, Sun ZJ. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle. EBioMedicine. 2024;14(104):105154.","journal-title":"EBioMedicine"},{"issue":"10","key":"1199_CR108","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","volume":"18","author":"MS Rha","year":"2021","unstructured":"Rha MS, Shin EC. Activation or exhaustion of CD8+ T cells in patients with COVID-19. Cell Mol Immunol. 2021;18(10):2325\u201333.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"1199_CR109","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/iid3.526","volume":"9","author":"Z Modabber","year":"2021","unstructured":"Modabber Z, Shahbazi M, Akbari R, et al. TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients. Immun Inflamm Dis. 2021;9(4):1707\u201315.","journal-title":"Immun Inflamm Dis"},{"issue":"10","key":"1199_CR110","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/jnr.24917","volume":"99","author":"K Roe","year":"2021","unstructured":"Roe K. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients. J Neurosci Res. 2021;99(10):2367\u201376.","journal-title":"J Neurosci Res"},{"issue":"6","key":"1199_CR111","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ymthe.2024.04.004","volume":"32","author":"T Ahn","year":"2024","unstructured":"Ahn T, Bae EA, Seo H. Decoding and overcoming T cell exhaustion: Epigenetic and transcriptional dynamics in CAR-T cells against solid tumors. Mol Ther. 2024;32(6):1617\u201327.","journal-title":"Mol Ther."},{"issue":"7","key":"1199_CR112","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2021.06.012","volume":"39","author":"GM Delgoffe","year":"2021","unstructured":"Delgoffe GM, Xu C, Mackall CL, et al. The role of exhaustion in CAR T cell therapy. Cancer Cell. 2021;39(7):885\u20138.","journal-title":"Cancer Cell"},{"issue":"7786","key":"1199_CR113","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn RC, Weber EW, Sotillo E, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576(7786):293\u2013300.","journal-title":"Nature"},{"issue":"1","key":"1199_CR114","doi-asserted-by":"publisher","first-page":"e001688","DOI":"10.1136\/jitc-2020-001688","volume":"9","author":"J Kumar","year":"2021","unstructured":"Kumar J, Kumar R, Kumar Singh A, et al. Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function. J Immunother Cancer. 2021;9(1):e001688.","journal-title":"J Immunother Cancer"},{"key":"1199_CR115","doi-asserted-by":"publisher","first-page":"103941","DOI":"10.1016\/j.ebiom.2022.103941","volume":"77","author":"D Gumber","year":"2022","unstructured":"Gumber D, Wang LD. Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion. EBioMedicine. 2022;77:103941.","journal-title":"EBioMedicine"},{"issue":"3","key":"1199_CR116","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8(3):239\u201345.","journal-title":"Nat Immunol"},{"issue":"13","key":"1199_CR117","doi-asserted-by":"publisher","first-page":"977394","DOI":"10.3389\/fimmu.2022.977394","volume":"23","author":"Z Gao","year":"2022","unstructured":"Gao Z, Feng Y, Xu J, et al. T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy. Front Immunol. 2022;23(13):977394.","journal-title":"Front Immunol"},{"issue":"2","key":"1199_CR118","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13577-022-00839-6","volume":"36","author":"K Roe","year":"2023","unstructured":"Roe K. Accelerated T-cell exhaustion: its potential role in autoimmune disease and hyperinflammatory disease pathogenesis. Hum Cell. 2023;36(2):866\u20139.","journal-title":"Hum Cell"},{"issue":"5","key":"1199_CR119","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/imcb.12444","volume":"99","author":"CJ Kwong","year":"2021","unstructured":"Kwong CJ, Selck C, Tahija K, et al. Harnessing CD8+ T-cell exhaustion to treat type 1 diabetes. Immunol Cell Biol. 2021;99(5):486\u201395.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"1199_CR120","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.kint.2019.01.040","volume":"96","author":"M Fribourg","year":"2019","unstructured":"Fribourg M, Anderson L, Fischman C, et al. T-cell exhaustion correlates with improved outcomes in kidney transplant recipients. Kidney Int. 2019;96(2):436\u201349.","journal-title":"Kidney Int"},{"issue":"9","key":"1199_CR121","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1111\/ajt.15870","volume":"20","author":"D Zou","year":"2020","unstructured":"Zou D, Dai Y, Zhang X, et al. T cell exhaustion is associated with antigen abundance and promotes transplant acceptance. Am J Transplant. 2020;20(9):2540\u201350.","journal-title":"Am J Transplant"},{"issue":"3","key":"1199_CR122","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/TP.0000000000003851","volume":"106","author":"A Angeletti","year":"2022","unstructured":"Angeletti A, Cantarelli C, Riella LV, et al. T-cell exhaustion in organ transplantation. Transplantation. 2022;106(3):489\u201399.","journal-title":"Transplantation"},{"issue":"4","key":"1199_CR123","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1074-7613(00)80628-7","volume":"9","author":"A Oxenius","year":"1998","unstructured":"Oxenius A, Zinkernagel RM, Hengartner H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity. 1998;9(4):449\u201357.","journal-title":"Immunity"},{"issue":"11","key":"1199_CR124","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","volume":"8","author":"DE Kaufmann","year":"2007","unstructured":"Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol. 2007;8(11):1246\u201354.","journal-title":"Nat Immunol"},{"issue":"5","key":"1199_CR125","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/COH.0000000000000094","volume":"9","author":"A Morou","year":"2014","unstructured":"Morou A, Palmer BE, Kaufmann DE. Distinctive features of CD4+ T cell dysfunction in chronic viral infections. Curr Opin HIV AIDS. 2014;9(5):446\u201351.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"1199_CR126","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, Joo V, Jacquier P, et al. T-cell exhaustion in HIV infection. Immunol Rev. 2019;292(1):149\u201363.","journal-title":"Immunol Rev"},{"issue":"21","key":"1199_CR127","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","volume":"27","author":"AM Miggelbrink","year":"2021","unstructured":"Miggelbrink AM, Jackson JD, Lorrey SJ, et al. CD4 T-cell exhaustion: Does it exist and what are its roles in cancer? Clin Cancer Res. 2021;27(21):5742\u201352.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1199_CR128","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.4049\/jimmunol.1101165","volume":"189","author":"P Antoine","year":"2012","unstructured":"Antoine P, Olislagers V, Huygens A, et al. Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. J Immunol. 2012;189(5):2665\u201372.","journal-title":"J Immunol"},{"issue":"16","key":"1199_CR129","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1128\/JVI.79.16.10514-10527.2005","volume":"79","author":"DG Brooks","year":"2005","unstructured":"Brooks DG, Teyton L, Oldstone MB, et al. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol. 2005;79(16):10514\u201327.","journal-title":"J Virol"},{"issue":"2","key":"1199_CR130","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford A, Angelosanto JM, Kao C, et al. Molecular and transcriptional basis of CD4\u207a T cell dysfunction during chronic infection. Immunity. 2014;40(2):289\u2013302.","journal-title":"Immunity"},{"issue":"8","key":"1199_CR131","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri2131","volume":"7","author":"CG Fathman","year":"2007","unstructured":"Fathman CG, Lineberry NB. Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol. 2007;7(8):599\u2013609.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1199_CR132","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.2106","volume":"16","author":"EA Said","year":"2010","unstructured":"Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med. 2010;16(4):452\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"1199_CR133","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JVI.02034-13","volume":"88","author":"F Porichis","year":"2014","unstructured":"Porichis F, Hart MG, Zupkosky J, et al. Differential impact of PD-1 and\/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions. J Virol. 2014;88(5):2508\u201318.","journal-title":"J Virol"},{"issue":"33","key":"1199_CR134","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.1303676111","volume":"111","author":"B Sarraj","year":"2014","unstructured":"Sarraj B, Ye J, Akl AI, et al. Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Proc Natl Acad Sci U S A. 2014;111(33):12145\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1199_CR135","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13046-021-02092-5","volume":"40","author":"I Morianos","year":"2021","unstructured":"Morianos I, Tsitsopoulou A, Potaris K, et al. Activin-A impedes the establishment of CD4+ T cell exhaustion and enhances anti-tumor immunity in the lung. J Exp Clin Cancer Res. 2021;40(1):295.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1199_CR136","doi-asserted-by":"publisher","first-page":"113797","DOI":"10.1016\/j.celrep.2024.113797","volume":"43","author":"W Zhou","year":"2024","unstructured":"Zhou W, Kawashima S, Ishino T, et al. Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment. Cell Rep. 2024;43(2):113797.","journal-title":"Cell Rep"},{"issue":"2","key":"1199_CR137","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaci.2016.04.013","volume":"138","author":"T Frenz","year":"2016","unstructured":"Frenz T, Grabski E, Buschj\u00e4ger D, et al. CD4(+) T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion. J Allergy Clin Immunol. 2016;138(2):586-589.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"1199_CR138","doi-asserted-by":"publisher","first-page":"3642832","DOI":"10.1155\/2017\/3642832","volume":"2017","author":"C Hawkins","year":"2017","unstructured":"Hawkins C, Shaginurova G, Shelton DA, et al. Local and systemic CD4+ T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis. J Immunol Res. 2017;2017:3642832.","journal-title":"J Immunol Res"},{"issue":"12","key":"1199_CR139","doi-asserted-by":"publisher","first-page":"627435","DOI":"10.3389\/fimmu.2021.627435","volume":"25","author":"W He","year":"2021","unstructured":"He W, Xiao K, Xu J, et al. Recurrent sepsis exacerbates CD4+ T cell exhaustion and decreases antiviral immune responses. Front Immunol. 2021;25(12):627435.","journal-title":"Front Immunol"},{"issue":"16","key":"1199_CR140","doi-asserted-by":"publisher","first-page":"e161812","DOI":"10.1172\/jci.insight.161812","volume":"8","author":"LM Jacobsen","year":"2023","unstructured":"Jacobsen LM, Diggins K, Blanchfield L, et al. Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes. JCI Insight. 2023;8(16):e161812.","journal-title":"JCI Insight"},{"issue":"5","key":"1199_CR141","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1365-2222.2010.03501.x","volume":"40","author":"D Shik","year":"2010","unstructured":"Shik D, Munitz A. Regulation of allergic inflammatory responses by inhibitory receptors. Clin Exp Allergy. 2010;40(5):700\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"1199_CR142","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1002\/eji.200425197","volume":"34","author":"E Oflazoglu","year":"2004","unstructured":"Oflazoglu E, Swart DA, Anders-Bartholo P, et al. Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo. Eur J Immunol. 2004;34(12):3326\u201336.","journal-title":"Eur J Immunol"},{"issue":"7","key":"1199_CR143","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.4049\/jimmunol.176.7.3909","volume":"176","author":"C Deppong","year":"2006","unstructured":"Deppong C, Juehne TI, Hurchla M, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol. 2006;176(7):3909\u201313.","journal-title":"J Immunol"},{"issue":"4","key":"1199_CR144","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/eji.201444778","volume":"45","author":"JW McAlees","year":"2015","unstructured":"McAlees JW, Lajoie S, Dienger K, et al. Differential control of CD4(+) T-cell subsets by the PD-1\/PD-L1 axis in a mouse model of allergic asthma. Eur J Immunol. 2015;45(4):1019\u201329.","journal-title":"Eur J Immunol"},{"issue":"2","key":"1199_CR145","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/1521-4141(200202)32:2<585::AID-IMMU585>3.0.CO;2-U","volume":"32","author":"PW Hellings","year":"2002","unstructured":"Hellings PW, Vandenberghe P, Kasran A, et al. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol. 2002;32(2):585\u201394.","journal-title":"Eur J Immunol"},{"issue":"9","key":"1199_CR146","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4049\/immunohorizons.2200056","volume":"6","author":"CA Castellanos","year":"2022","unstructured":"Castellanos CA, Hiam-Galvez KJ, Ishido S, et al. MARCH1 controls an exhaustion-like program of effector CD4+ T cells promoting allergic airway inflammation. Immunohorizons. 2022;6(9):684\u201392.","journal-title":"Immunohorizons"},{"issue":"1","key":"1199_CR147","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12931-023-02448-9","volume":"24","author":"SY Ahn","year":"2023","unstructured":"Ahn SY, Lee J, Lee DH, et al. Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice. Respir Res. 2023;24(1):160.","journal-title":"Respir Res"},{"issue":"2","key":"1199_CR148","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2004.03.050","volume":"114","author":"MC Munthe-Kaas","year":"2004","unstructured":"Munthe-Kaas MC, Carlsen KH, Helms PJ, et al. CTLA-4 polymorphisms in allergy and asthma and the TH1\/ TH2 paradigm. J Allergy Clin Immunol. 2004;114(2):280\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1199_CR149","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/cea.13017","volume":"47","author":"K Bratke","year":"2017","unstructured":"Bratke K, Fritz L, Nokodian F, et al. Differential regulation of PD-1 and its ligands in allergic asthma. Clin Exp Allergy. 2017;47(11):1417\u201325.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"1199_CR150","first-page":"517","volume":"17","author":"A Mosayebian","year":"2018","unstructured":"Mosayebian A, Koohini Z, Hossein-Nataj H, et al. Elevated expression of Tim-3 and PD-1 immune checkpoint receptors on T-CD4+ lymphocytes of patients with asthma. Iran J Allergy Asthma Immunol. 2018;17(6):517\u201325.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"7920","key":"1199_CR151","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41586-022-04916-6","volume":"607","author":"SW Hong","year":"2022","unstructured":"Hong SW, Krueger PD, Osum KC, et al. Immune tolerance of food is mediated by layers of CD4+ T cell dysfunction. Nature. 2022;607(7920):762\u20138.","journal-title":"Nature"},{"issue":"6","key":"1199_CR152","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/eji.202149572","volume":"52","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liu S, Li Y, et al. Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma. Eur J Immunol. 2022;52(6):978\u201393.","journal-title":"Eur J Immunol"},{"issue":"3","key":"1199_CR153","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","volume":"136","author":"M Jutel","year":"2015","unstructured":"Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556\u201368.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1199_CR154","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","volume":"23","author":"SR Durham","year":"2023","unstructured":"Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023;23(5):317\u201328.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1199_CR155","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/all.13138","volume":"72","author":"MH Shamji","year":"2017","unstructured":"Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017;72(8):1156\u201373.","journal-title":"Allergy"},{"issue":"1","key":"1199_CR156","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaip.2023.11.027","volume":"12","author":"JA Layhadi","year":"2024","unstructured":"Layhadi JA, Lalioti A, Palmer E, et al. Mechanisms and predictive biomarkers of allergen immunotherapy in the clinic. J Allergy Clin Immunol Pract. 2024;12(1):59\u201366.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"1199_CR157","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/all.12878","volume":"71","author":"G Varricchi","year":"2016","unstructured":"Varricchi G, Harker J, Borriello F, et al. T follicular helper (Tfh) cells in normal immune responses and in allergic disorders. Allergy. 2016;71(8):1086\u201394.","journal-title":"Allergy"},{"issue":"1","key":"1199_CR158","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2016.04.021","volume":"139","author":"T Kobayashi","year":"2017","unstructured":"Kobayashi T, Iijima K, Dent AL, et al. Follicular helper T cells mediate IgE antibody response to airborne allergens. J Allergy Clin Immunol. 2017;139(1):300-313.e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1199_CR159","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/all.14639","volume":"76","author":"Y Yao","year":"2021","unstructured":"Yao Y, Chen CL, Yu D, et al. Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy. Allergy. 2021;76(2):456\u201370.","journal-title":"Allergy"},{"issue":"2","key":"1199_CR160","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/cells11020212","volume":"11","author":"GF Pav\u00f3n-Romero","year":"2022","unstructured":"Pav\u00f3n-Romero GF, Parra-Vargas MI, Ram\u00edrez-Jim\u00e9nez F, et al. Allergen immunotherapy: Current and future trends. Cells. 2022;11(2):212.","journal-title":"Cells"},{"issue":"4","key":"1199_CR161","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/all.15945","volume":"79","author":"M Zemelka-Wiacek","year":"2024","unstructured":"Zemelka-Wiacek M, Agache I, Akdis CA, et al. Hot topics in allergen immunotherapy, 2023: Current status and future perspective. Allergy. 2024;79(4):823\u201342.","journal-title":"Allergy"},{"issue":"6","key":"1199_CR162","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","volume":"140","author":"MH Shamji","year":"2017","unstructured":"Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017;140(6):1485\u201398.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1199_CR163","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaci.2022.01.016","volume":"149","author":"MH Shamji","year":"2022","unstructured":"Shamji MH, Sharif H, Layhadi JA, et al. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immunol. 2022;149(3):791\u2013801.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1199_CR164","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2011.08.034","volume":"129","author":"E Wambre","year":"2012","unstructured":"Wambre E, DeLong JH, James EA, et al. Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol. 2012;129(2):544\u201351.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"1199_CR165","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/ACI.0000000000000216","volume":"15","author":"E Wambre","year":"2015","unstructured":"Wambre E. Effect of allergen-specific immunotherapy on CD4+ T cells. Curr Opin Allergy Clin Immunol. 2015;15(6):581\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"401","key":"1199_CR166","doi-asserted-by":"publisher","first-page":"eaam9171","DOI":"10.1126\/scitranslmed.aam9171","volume":"9","author":"E Wambre","year":"2017","unstructured":"Wambre E, Bajzik V, DeLong JH, et al. A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Sci Transl Med. 2017;9(401):eaam9171.","journal-title":"Sci Transl Med."},{"issue":"4","key":"1199_CR167","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jaci.2022.06.024","volume":"150","author":"T Iinuma","year":"2022","unstructured":"Iinuma T, Kiuchi M, Hirahara K, et al. Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic TH2 cells and clonal conversion. J Allergy Clin Immunol. 2022;150(4):850-860.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1199_CR168","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jaci.2022.11.030","volume":"151","author":"JA Layhadi","year":"2023","unstructured":"Layhadi JA, Moya R, Tan TJ, et al. Single-cell RNA sequencing identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract. J Allergy Clin Immunol. 2023;151(5):1357-1370.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1199_CR169","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/j.1365-2222.2008.03116.x","volume":"38","author":"M Okano","year":"2008","unstructured":"Okano M, Otsuki N, Azuma M, et al. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis. Clin Exp Allergy. 2008;38(12):1891\u2013900.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"1199_CR170","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/ncomms5741","volume":"3","author":"BR Burton","year":"2014","unstructured":"Burton BR, Britton GJ, Fang H, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;3(5):4741.","journal-title":"Nat Commun"},{"issue":"1","key":"1199_CR171","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1038\/s41598-018-31757-z","volume":"8","author":"S Rosskopf","year":"2018","unstructured":"Rosskopf S, Jahn-Schmid B, Schmetterer KG, et al. PD-1 has a unique capacity to inhibit allergen-specific human CD4+ T cell responses. Sci Rep. 2018;8(1):13543.","journal-title":"Sci Rep"},{"issue":"6","key":"1199_CR172","doi-asserted-by":"publisher","first-page":"e37980","DOI":"10.1371\/journal.pone.0037980","volume":"7","author":"AM Riccio","year":"2012","unstructured":"Riccio AM, Saverino D, Pesce G, et al. Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10. PLoS ONE. 2012;7(6):e37980.","journal-title":"PLoS ONE"},{"issue":"9","key":"1199_CR173","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1111\/all.14896","volume":"76","author":"SH Wang","year":"2021","unstructured":"Wang SH, Zissler UM, Buettner M, et al. An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen-specific immunotherapy. Allergy. 2021;76(9):2827\u201339.","journal-title":"Allergy"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01199-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:47:46Z","timestamp":1742179666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01199-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01199-5","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"6 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18"}}